Healthcare -
Biotechnology - NASDAQ - US
$ 1.16
-0.855 %
$ 34.7 M
Market Cap
-0.58
P/E
ANTX - TOTAL EQUITY
Total Equity ANTX - AN2 Therapeutics, Inc.
125 M
LAST VALUE
115.18%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR